| scholarly article | Q13442814 |
| P356 | DOI | 10.3892/ETM.2014.2059 |
| P8608 | Fatcat ID | release_2m4pauczize35dw5j7kpsdxtqe |
| P932 | PMC publication ID | 4247311 |
| P698 | PubMed publication ID | 25452786 |
| P5875 | ResearchGate publication ID | 269178940 |
| P2093 | author name string | Haiyan Wang | |
| Shaoyan Zhang | |||
| Luping Zhang | |||
| Yannian Li | |||
| P2860 | cites work | Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6. | Q51045048 |
| Alpha-fetoprotein impairs APC function and induces their apoptosis | Q56881043 | ||
| Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival | Q56986695 | ||
| Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation | Q71107364 | ||
| Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts | Q71148644 | ||
| Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells | Q71607047 | ||
| Angiogenesis and metastasis | Q73129425 | ||
| Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats | Q73592153 | ||
| Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution | Q24679240 | ||
| Dendritic cells and the control of immunity | Q27860918 | ||
| Multiple signals are required for maturation of human dendritic cells mobilized in vivo with Flt3 ligand | Q28201287 | ||
| Vascular endothelial growth factor is a secreted angiogenic mitogen | Q28646475 | ||
| The biology of vascular endothelial growth factor | Q29615946 | ||
| The dendritic cell system and its role in immunogenicity | Q29619870 | ||
| Functional modulation of dendritic cells to suppress adaptive immune responses | Q35093120 | ||
| Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells | Q35764615 | ||
| Ovarian cancer progression is controlled by phenotypic changes in dendritic cells | Q35826026 | ||
| Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancer | Q35871752 | ||
| Vascular endothelial growth factor-C promotes alloimmunity by amplifying antigen-presenting cell maturation and lymphangiogenesis | Q35921437 | ||
| Effect of siRNA-mediated downregulation of VEGF in Tca8113 cells on the activity of monocyte-derived dendritic cells | Q35995289 | ||
| Avirulent Toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironment | Q36986107 | ||
| Inactivation of tumor-specific CD8⁺ CTLs by tumor-infiltrating tolerogenic dendritic cells | Q37250817 | ||
| Intrinsic immune alterations in renal cell carcinoma and emerging immunotherapeutic approaches | Q38099023 | ||
| Vascular endothelial growth factor-A enhances indoleamine 2,3-dioxygenase expression by dendritic cells and subsequently impacts lymphocyte proliferation | Q39091474 | ||
| A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics | Q40554467 | ||
| Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation | Q40736369 | ||
| Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
| Clinical significance of the determination of angiogenic factors | Q41372744 | ||
| Dendritic cells: unique leukocyte populations which control the primary immune response | Q41621775 | ||
| Dendritic cells as adjuvants for immune-mediated resistance to tumors | Q41649620 | ||
| Overexpression and immunosuppressive functions of transforming growth factor 1, vascular endothelial growth factor and interleukin-10 in epithelial ovarian cancer | Q42984756 | ||
| Gangliosides from human melanoma tumors impair dendritic cell differentiation from monocytes and induce their apoptosis | Q44368619 | ||
| Decreased antigen presentation by dendritic cells in patients with breast cancer. | Q44562482 | ||
| Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation | Q45195923 | ||
| Serum vascular endothelial growth factor is often elevated in disseminated cancer. | Q48709403 | ||
| Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors. | Q50514753 | ||
| P433 | issue | 1 | |
| P921 | main subject | endothelium | Q111140 |
| dendritic cell | Q506253 | ||
| P304 | page(s) | 120-124 | |
| P577 | publication date | 2014-11-11 | |
| P1433 | published in | Experimental and Therapeutic Medicine | Q23979083 |
| P1476 | title | Inhibition of vascular endothelial growth factor by small interfering RNA upregulates differentiation, maturation and function of dendritic cells | |
| P478 | volume | 9 |
| Q50204216 | Angiogenesis for tumor vascular normalization of Endostar on hepatoma 22 tumor-bearing mice is involved in the immune response |
| Q36181047 | Biophysical Properties and Motility of Human Mature Dendritic Cells Deteriorated by Vascular Endothelial Growth Factor through Cytoskeleton Remodeling |
| Q38777795 | Tumor-derived factors modulating dendritic cell function |
Search more.